UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 6, 2019
Axcelis Technologies, Inc.
(Exact name of registrant as specified in its charter)
Delaware |
|
000-30941 |
|
34-1818596 |
(State or other jurisdiction |
|
(Commission |
|
(IRS Employer |
of incorporation) |
|
File Number) |
|
Identification No.) |
108 Cherry Hill Drive, Beverly, Massachusetts |
|
01915 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrants telephone number, including area code: (978) 787-4000
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
Common Stock, par value $0.001 per share |
|
ACLS |
|
NASDAQ Global Select Market |
Item 2.02 Results of Operations and Financial Condition
On August 6, 2019, Axcelis Technologies, Inc. (the Company) issued a press release regarding its financial results for its quarter ended June 30, 2019. The Companys press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
Exhibit No. |
|
Description |
|
|
|
99.1 |
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: August 6, 2019 |
Axcelis Technologies, Inc. | |
|
|
|
|
By: |
/s/ KEVIN J. BREWER |
|
|
Kevin J. Brewer |
|
|
Executive Vice President |
|
|
and Chief Financial Officer |
News Release
AXCELIS ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER 2019
Company Reports Solid Gross Margin Performance and Increases Full Year Gross Margin Estimates
BEVERLY, Mass. August 6, 2019Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the second quarter ended June 30, 2019.
The Company reported second quarter revenue of $74.3 million, compared to $91.5 million for the first quarter of 2019. Operating profit for the quarter was $2.0 million, compared to $7.1 million for the first quarter. Net income for the quarter was $0.6 million, or $0.02 per diluted share, compared to net income for the first quarter of $6.1 million, or $0.18 per diluted share. Gross margin for the quarter was 42.7%, compared to 41.0% in the first quarter. Cash, cash equivalents and restricted cash were $143.2 million on June 30, 2019, compared to $170.0 million on March 31, 2019.
President and CEO Mary Puma commented, We remain committed to managing for profitability and preparing for the upturn. We are focused on revenue growth through investments in innovative technology for Purion product line extensions targeting new market segments. Puma continued, These new Purion products are designed to create a sustainable competitive differentiation to support our customers technology and manufacturing needs. These Purion products will fuel our growth when the market recovers.
Executive Vice President and CFO Kevin Brewer noted, I am pleased with our second quarter gross margin results. Purion product extensions and margin improvement initiatives, as well as mix, are fueling strong gross margin performance, despite lower revenues. We now expect full year average gross margin to be 41.0 to 41.5%, up from 40.0 to 41.0%.
Business Outlook
For the third quarter ending September 30, 2019, Axcelis expects revenues to be in the range of $65-75 million. Gross margin in the third quarter is expected to be approximately 41%. Third quarter operating profit is forecasted to be approximately ($1.2) million to $2.0 million. Earnings per diluted share is expected to be in the range of breakeven, plus or minus $0.05.
Second Quarter 2019 Conference Call
The Company will host a call to discuss the results for the second quarter 2019 on Wednesday, August 7, 2019 at 8:30 am ET. The call will be available to interested listeners via an audio webcast that can be accessed through the Investors page of Axcelis website at www.axcelis.com, or by dialing 866.588.8911 (707.294.1561
outside North America). Participants calling into the conference call will be requested to provide the company name, Axcelis Technologies, and Conference ID: 2690958. Webcast replays will be available for 30 days following the call.
Safe Harbor Statement
This press release and the conference call contain forward-looking statements under the Private Securities Litigation Reform Act safe harbor provisions. These statements, which include our expectations for spending in our industry and guidance for future financial performance, are based on managements current expectations and should be viewed with caution. They are subject to various risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are outside the control of the Company, including that customer decisions to place orders or our product shipments may not occur when we expect, that orders may not be converted to revenue in any particular quarter, or at all, whether demand will continue for the semiconductor equipment we produce or, if not, whether we can successfully meet changing market requirements, and whether we will be able to maintain continuity of business relationships with and purchases by major customers. Increased competitive pressure on sales and pricing, increases in material and other production costs that cannot be recouped in product pricing and instability caused by changing global economic, political or financial conditions could also cause actual results to differ materially from those in our forward-looking statements. These risks and other risk factors relating to Axcelis are described more fully in the most recent Form 10-K filed by Axcelis and in other documents filed from time to time with the Securities and Exchange Commission.
About Axcelis:
Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 40 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.
Company Contacts
Investor Relations:
Doug Lawson
978.787.9552
Editorial/Media:
Maureen Hart
978.787.4266
Axcelis Technologies, Inc.
Consolidated Statements of Operations
(In thousands, except per share amounts)
(Unaudited)
|
|
Three months ended |
|
Six months ended |
| ||||||||
|
|
June 30, |
|
June 30, |
| ||||||||
|
|
2019 |
|
2018 |
|
2019 |
|
2018 |
| ||||
Revenue: |
|
|
|
|
|
|
|
|
| ||||
Product |
|
$ |
68,714 |
|
$ |
112,521 |
|
$ |
152,911 |
|
$ |
228,543 |
|
Services |
|
5,591 |
|
6,812 |
|
12,871 |
|
12,975 |
| ||||
Total revenue |
|
74,305 |
|
119,333 |
|
165,782 |
|
241,518 |
| ||||
Cost of revenue: |
|
|
|
|
|
|
|
|
| ||||
Product |
|
37,188 |
|
63,913 |
|
84,518 |
|
132,287 |
| ||||
Services |
|
5,368 |
|
6,420 |
|
12,009 |
|
13,075 |
| ||||
Total cost of revenue |
|
42,556 |
|
70,333 |
|
96,527 |
|
145,362 |
| ||||
Gross profit |
|
31,749 |
|
49,000 |
|
69,255 |
|
96,156 |
| ||||
Operating expenses: |
|
|
|
|
|
|
|
|
| ||||
Research and development |
|
13,720 |
|
12,553 |
|
27,405 |
|
24,786 |
| ||||
Sales and marketing |
|
8,436 |
|
8,912 |
|
17,354 |
|
17,323 |
| ||||
General and administrative |
|
7,583 |
|
8,268 |
|
15,390 |
|
16,278 |
| ||||
Total operating expenses |
|
29,739 |
|
29,733 |
|
60,149 |
|
58,387 |
| ||||
Income from operations |
|
2,010 |
|
19,267 |
|
9,106 |
|
37,769 |
| ||||
Other (expense) income: |
|
|
|
|
|
|
|
|
| ||||
Interest income |
|
845 |
|
515 |
|
1,686 |
|
925 |
| ||||
Interest expense |
|
(1,311 |
) |
(1,127 |
) |
(2,541 |
) |
(2,464 |
) | ||||
Other, net |
|
(189 |
) |
(1,016 |
) |
(362 |
) |
(1,118 |
) | ||||
Total other expense |
|
(655 |
) |
(1,628 |
) |
(1,217 |
) |
(2,657 |
) | ||||
Income before income taxes |
|
1,355 |
|
17,639 |
|
7,889 |
|
35,112 |
| ||||
Income tax provision |
|
799 |
|
2,970 |
|
1,271 |
|
6,528 |
| ||||
Net income |
|
$ |
556 |
|
$ |
14,669 |
|
$ |
6,618 |
|
$ |
28,584 |
|
Net income per share: |
|
|
|
|
|
|
|
|
| ||||
Basic |
|
$ |
0.02 |
|
$ |
0.46 |
|
$ |
0.20 |
|
$ |
0.89 |
|
Diluted |
|
$ |
0.02 |
|
$ |
0.43 |
|
$ |
0.19 |
|
$ |
0.84 |
|
Shares used in computing net income per share: |
|
|
|
|
|
|
|
|
| ||||
Basic weighted average common shares |
|
32,729 |
|
32,214 |
|
32,706 |
|
32,154 |
| ||||
Diluted weighted average common shares |
|
33,901 |
|
33,942 |
|
34,064 |
|
34,048 |
|
Axcelis Technologies, Inc.
Consolidated Balance Sheets
(In thousands, except per share amounts)
(Unaudited)
|
|
June 30, |
|
December 31, |
| ||
|
|
2019 |
|
2018 |
| ||
ASSETS |
|
|
|
|
| ||
Current assets: |
|
|
|
|
| ||
Cash and cash equivalents |
|
$ |
136,340 |
|
$ |
177,993 |
|
Short-term restricted cash |
|
149 |
|
|
| ||
Accounts receivable, net |
|
62,279 |
|
78,727 |
| ||
Inventories, net |
|
135,141 |
|
129,000 |
| ||
Prepaid expenses and other current assets |
|
11,448 |
|
11,051 |
| ||
Total current assets |
|
345,357 |
|
396,771 |
| ||
Property, plant and equipment, net |
|
24,326 |
|
41,149 |
| ||
Operating lease assets |
|
6,431 |
|
|
| ||
Finance lease assets, net |
|
22,563 |
|
|
| ||
Long-term restricted cash |
|
6,675 |
|
6,909 |
| ||
Deferred income taxes |
|
70,598 |
|
71,939 |
| ||
Other assets |
|
41,132 |
|
31,673 |
| ||
Total assets |
|
$ |
517,082 |
|
$ |
548,441 |
|
LIABILITIES AND STOCKHOLDERS EQUITY |
|
|
|
|
| ||
Current liabilities: |
|
|
|
|
| ||
Accounts payable |
|
$ |
21,771 |
|
$ |
35,955 |
|
Accrued compensation |
|
7,695 |
|
19,218 |
| ||
Warranty |
|
4,045 |
|
4,819 |
| ||
Income taxes |
|
329 |
|
462 |
| ||
Deferred revenue |
|
10,176 |
|
19,513 |
| ||
Current portion of finance lease obligation |
|
108 |
|
|
| ||
Other current liabilities |
|
7,960 |
|
5,030 |
| ||
Total current liabilities |
|
52,084 |
|
84,997 |
| ||
Finance lease obligation |
|
48,441 |
|
47,757 |
| ||
Long-term deferred revenue |
|
3,904 |
|
3,071 |
| ||
Other long-term liabilities |
|
7,187 |
|
4,279 |
| ||
Total liabilities |
|
111,616 |
|
140,104 |
| ||
Commitments and contingencies |
|
|
|
|
| ||
Stockholders equity: |
|
|
|
|
| ||
Common stock, $0.001 par value, 75,000 shares authorized; 32,297 shares issued and outstanding at June 30, 2019; 32,558 shares issued and outstanding at December 31, 2018 |
|
32 |
|
33 |
| ||
Additional paid-in capital |
|
556,283 |
|
565,116 |
| ||
Accumulated deficit |
|
(150,642 |
) |
(157,260 |
) | ||
Accumulated other comprehensive (loss) income |
|
(207 |
) |
448 |
| ||
Total stockholders equity |
|
405,466 |
|
408,337 |
| ||
Total liabilities and stockholders equity |
|
$ |
517,082 |
|
$ |
548,441 |
|